Works matching IS 10584838 AND DT 2018 AND VI 67 AND IP 10


Results: 31
    1
    2
    3
    4
    5
    6
    7

    Cover.

    Published in:
    Clinical Infectious Diseases, 2018, v. 67, n. 10, p. NP, doi. 10.1093/cid/ciy855
    Publication type:
    Article
    8

    News.

    Published in:
    Clinical Infectious Diseases, 2018, v. 67, n. 10, p. i, doi. 10.1093/cid/ciy730
    Publication type:
    Article
    9

    Clostridium difficile Guidelines.

    Published in:
    Clinical Infectious Diseases, 2018, v. 67, n. 10, p. 1639, doi. 10.1093/cid/ciy249
    By:
    • Collins, Deirdre A;
    • Riley, Thomas V
    Publication type:
    Article
    10

    In the Literature.

    Published in:
    Clinical Infectious Diseases, 2018, v. 67, n. 10, p. iii, doi. 10.1093/cid/ciy831
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Reply to Collins and Riley.

    Published in:
    Clinical Infectious Diseases, 2018, v. 67, n. 10, p. 1640, doi. 10.1093/cid/ciy251
    By:
    • McDonald, L Clifford;
    • Gerding, Dale N;
    • Johnson, Stuart
    Publication type:
    Article
    21
    22
    23
    24
    25
    26

    A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal, West Africa

    Published in:
    Clinical Infectious Diseases, 2018, v. 67, n. 10, p. 1588, doi. 10.1093/cid/ciy324
    By:
    • Ba, Selly;
    • Raugi, Dana N;
    • Smith, Robert A;
    • Sall, Fatima;
    • Faye, Khadim;
    • Hawes, Stephen E;
    • Sow, Papa Salif;
    • Seydi, Moussa;
    • Gottlieb, Geoffrey S;
    • Group, University of Washington–Dakar HIV-2 Study
    Publication type:
    Article
    27
    28
    29
    30
    31

    Erratum.

    Published in:
    2018
    Publication type:
    Correction Notice